Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, supplying promising developments throughout many clinical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, far more responsible choice for therapeutic use,